Medical devices, healthcare technology and the business of care
510(k) clearance · K254090

I-View

Hologic, Inc. · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONK254090

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K254090 on September 2, 2026, covering Hologic, Inc.'s I-View® contrast-enhanced digital mammography software, version 3.0, a Class II full-field digital mammography system under 21 CFR 892.1715 with product code MUE. The submission was dated December 16, 2025 and received December 19, 2025. The device is optional CEDM software for the Envision Mammography Platform (P080003/S009), acquiring low- and high-energy 2D images during a single compression.

The comparison document names I-View® CEDM software cleared as K123873 (January 29, 2013) as the predicate, and states the only indication difference is the imaging platform used to obtain images. SE denotes 510(k) clearance, not PMA approval. The source does not include the clearance letter's full text, performance data, or any statement on clinical accuracy, so those remain unknown.

The summary lists IEC 62304:2015 and ISO 14971:2019 as standards and describes use as an adjunct following mammography and/or ultrasound to localize a known or suspected lesion, with MQSA-qualified interpreting physicians and radiologists as end users.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254090
Regulatory pathway
510(k) premarket notification
Applicant
Hologic, Inc.
Product code
MUE
Decision code
SESE
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Full Field Digital, System, X-Ray, Mammographic.

Applicant
Hologic, Inc.
Product code
MUE
FDA device class
2

FDA decision timeline

  1. K254090 received

    Application receipt date recorded by FDA.

  2. K254090 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MUE

Product / regulatory recordCompanyPathwayDecision dateSource
Siemens Medical Solutions USA, Inc.510(k) clearanceJun 18, 2026FDA
Vieworks Co., Ltd.510(k) clearanceMay 28, 2026FDA
GE Medical Systems SCS510(k) clearanceMar 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hologic, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Newark, DE

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records